MART-10, a novel vitamin D analog, inhibits head and neck squamous carcinoma cells growth through cell cycle arrest at G0/G1 with upregulation of p21 and p27 and downregulation of telomerase

Journal of Steroid Biochemistry and Molecular Biology

Volumn 138, Issue , 2013, Pages 427-434

  Chiang, Kun Chun ^a,b   Yeh, Chun Nan ^a   Hsu, Jun Te ^a   Chen, Li Wei ^a   Kuo, Sheng Fong ^a   Sun, Chi Chin ^a   Huang, Cheng Cheng ^a   Pang, Jong Hwei S ^b   Flanagan, John N ^c   Takano, Masashi ^d   Kittaka, Atsushi ^d   Juang, Horng Heng ^b   Yang, Shih Wei ^a   Chen, Tai C ^e,f  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d TEIKYO UNIVERSITY   (Japan)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f NONE   (United States)

Author keywords

Cell cycle; Head and neck cancer; MART 10; Proliferation; SCC; Vitamin D analog

Indexed keywords

KI 67 ANTIGEN; MART 10; PROTEIN P21; PROTEIN P27; TELOMERASE; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE;

ANTIGEN EXPRESSION; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER GROWTH; CARCINOMA CELL; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CONTROLLED STUDY; DOWN REGULATION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; UPREGULATION;

EID: 84885505961     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2013.09.002     Document Type: Article

References (41)

1. M. Muto, M. Nakane, C. Katada, Y. Sano, A. Ohtsu, H. Esumi, S. Ebihara, and S. Yoshida Squamous cell carcinoma in situ at oropharyngeal and hypopharyngeal mucosal sites Cancer 101 6 2004 1375 1381 (Pubitemid 39180393)
2. R.I. Haddad, and D.M. Shin Recent advances in head and neck cancer N. Engl. J. Med. 359 11 2008 1143 1154
3. A.K. Azad, I. Bairati, E. Samson, D. Cheng, M. Mirshams, X. Qiu, S. Savas, J. Waldron, C. Wang, D. Goldstein, W. Xu, F. Meyer, and G. Liu Validation of genetic sequence variants as prognostic factors in early-stage head and neck squamous cell cancer survival Clin. Cancer Res. 18 1 2012 196 206
4. K.K. Deeb, D.L. Trump, and C.S. Johnson Vitamin D signalling pathways in cancer: potential for anticancer therapeutics Nat. Rev. Cancer 7 9 2007 684 700 (Pubitemid 47327412)
5. K.C. Chiang, and T.C. Chen The anti-cancer actions of vitamin D Anti-cancer Agents Med. Chem. 13 1 2013 126 139
6. M.J. Tsai, and B.W. O'Malley Molecular mechanisms of action of steroid/thyroid receptor superfamily members Annu. Rev. Biochem. 63 1994 451 486 (Pubitemid 24218640)
7. M.F. Holick Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease Am. J. Clin. Nutr. 80 6 Suppl. 2004 1678S 1688S
8. T.C. Chen, and M.F. Holick Vitamin D and prostate cancer prevention and treatment Trends Endocrinol. Metab. 14 9 2003 423 430 (Pubitemid 37392215)
9. J.N. Flanagan, S. Zheng, K.C. Chiang, A. Kittaka, T. Sakaki, S. Nakabayashi, X. Zhao, R.A. Spanjaard, K.S. Persons, J.S. Mathieu, M.F. Holick, and T.C. Chen Evaluation of 19-nor-2alpha-(3-hydroxypropyl)-1alpha,25- dihydroxyvitamin D3 as a therapeutic agent for androgen-dependent prostate cancer Anticancer Res. 29 9 2009 3547 3553
10. K.C. Chiang, K.S. Persons, N.W. Istfan, M.F. Holick, and T.C. Chen Fish oil enhances the antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 on liver cancer cells Anticancer Res. 29 9 2009 3591 3596
11. G. Hager, M. Formanek, C. Gedlicka, D. Thurnher, B. Knerer, and J. Kornfehl 1,25(OH)2 vitamin D3 induces elevated expression of the cell cycle-regulating genes P21 and P27 in squamous carcinoma cell lines of the head and neck Acta oto-laryngologica 121 1 2001 103 109 (Pubitemid 32205033)
12. C. Gedlicka, G. Hager, M. Weissenbock, W. Gedlicka, B. Knerer, J. Kornfehl, and M. Formanek 1,25(OH)2Vitamin D3 induces elevated expression of the cell cycle inhibitor p18 in a squamous cell carcinoma cell line of the head and neck J. Oral Pathol. Med. 35 8 2006 472 478 (Pubitemid 44212901)
13. Y. Ma, W.D. Yu, A.A. Hidalgo, W. Luo, R. Delansorne, C.S. Johnson, and D.L. Trump Inecalcitol, an analog of 1,25D3, displays enhanced antitumor activity through the induction of apoptosis in a squamous cell carcinoma model system Cell Cycle 12 5 2013 743 752
14. K. Ono, A. Yoshida, N. Saito, T. Fujishima, S. Honzawa, Y. Suhara, S. Kishimoto, T. Sugiura, K. Waku, H. Takayama, and A. Kittaka Efficient synthesis of 2-modified 1alpha,25-dihydroxy-19-norvitamin D3 with Julia olefination: high potency in induction of differentiation on HL-60 cells J. Org. Chem. 68 19 2003 7407 7415 (Pubitemid 37122492)
15. T.C. Chen, K.S. Persons, S. Zheng, J. Mathieu, M.F. Holick, Y.F. Lee, B. Bao, M.A. Arai, and A. Kittaka Evaluation of C-2-substituted 19-nor-1alpha,25-dihydroxyvitamin D3 analogs as therapeutic agents for prostate cancer J. Steroid. Biochem. Mol. Biol. 103 3-5 2007 717 720 (Pubitemid 46401314)
16. D. Iglesias-Gato, S. Zheng, J.N. Flanagan, L. Jiang, A. Kittaka, T. Sakaki, K. Yamamoto, T. Itoh, N.K. Lebrasseur, G. Norstedt, and T.C. Chen Substitution at carbon 2 of 19-nor-1alpha,25-dihydroxyvitamin D3 with 3-hydroxypropyl group generates an analogue with enhanced chemotherapeutic potency in PC-3 prostate cancer cells J. Steroid. Biochem. Mol. Biol. 127 3-5 2011 269 275
17. K.C. Chiang, C.N. Yeh, H.Y. Chen, J.M. Lee, H.H. Juang, M.F. Chen, M. Takano, A. Kittaka, and T.C. Chen 19-Nor-2alpha-(3-hydroxypropyl)-1alpha,25- dihydroxyvitamin D3 (MART-10) is a potent cell growth regulator with enhanced chemotherapeutic potency in liver cancer cells Steroids 76 13 2011 1513 1519
18. K.C. Chiang, C.N. Yeh, S.C. Chen, S.C. Shen, J.T. Hsu, T.S. Yeh, J.H. Pang, L.J. Su, M. Takano, A. Kittaka, H.H. Juang, and T.C. Chen MART-10, a new generation of vitamin D analog, is more potent than 1alpha,25-dihydroxyvitamin D(3) in inhibiting cell proliferation and inducing apoptosis in ER+ MCF-7 breast cancer cells eCAM 2012 2012 310872
19. K.C. Chiang, C.N. Yeh, J.T. Hsu, T.S. Yeh, Y.Y. Jan, C.T. Wu, H.Y. Chen, S.C. Jwo, M. Takano, A. Kittaka, H.H. Juang, and T.C. Chen Evaluation of the potential therapeutic role of a new generation of vitamin D analog, MART-10, in human pancreatic cancer cells in vitro and in vivo Cell cycle 12 8 2013 1316 1325
20. W. Ouyang, Q. Ma, J. Li, D. Zhang, Z.G. Liu, A.K. Rustgi, and C. Huang Cyclin D1 induction through IkappaB kinase beta/nuclear factor-kappaB pathway is responsible for arsenite-induced increased cell cycle G1-S phase transition in human keratinocytes Cancer Res 65 20 2005 9287 9293 (Pubitemid 41507995)
21. I. Vermes, C. Haanen, and C. Reutelingsperger Flow cytometry of apoptotic cell death J. Immunol. Methods 243 1-2 2000 167 190
22. Y. Ohyama, K. Ozono, M. Uchida, T. Shinki, S. Kato, T. Suda, O. Yamamoto, M. Noshiro, and Y. Kato Identification of a vitamin D-responsive element in the 5'-flanking region of the rat 25-hydroxyvitamin D3 24-hydroxylase gene J. Biol. Chem. 269 14 1994 10545 10550
23. D.M. Kerry, P.P. Dwivedi, C.N. Hahn, H.A. Morris, J.L. Omdahl, and B.K. May Transcriptional synergism between vitamin D-responsive elements in the rat 25-hydroxyvitamin D3 24-hydroxylase (CYP24) promoter J. Biol. Chem. 271 47 1996 29715 29721 (Pubitemid 26389597)
24. E. Jaruga, S. Salvioli, J. Dobrucki, S. Chrul, J. Bandorowicz-Pikula, E. Sikora, C. Franceschi, A. Cossarizza, and G. Bartosz Apoptosis-like, reversible changes in plasma membrane asymmetry and permeability, and transient modifications in mitochondrial membrane potential induced by curcumin in rat thymocytes FEBS Lett. 433 3 1998 287 293 (Pubitemid 128369980)
25. G.J. Miller Vitamin D and prostate cancer: biologic interactions and clinical potentials Cancer Metast. Rev. 17 4 1998 353 360
26. G.M. Zinser, K. McEleney, and J. Welsh Characterization of mammary tumor cell lines from wild type and vitamin D3 receptor knockout mice Mol. Cell. Endocrinol. 200 1-2 2003 67 80 (Pubitemid 36331916)
27. S. Hourai, T. Fujishima, A. Kittaka, Y. Suhara, H. Takayama, N. Rochel, and D. Moras Probing a water channel near the A-ring of receptor-bound 1 alpha,25-dihydroxyvitamin D3 with selected 2 alpha-substituted analogues J. Med. Chem. 49 17 2006 5199 5205 (Pubitemid 44260215)
28. Y. Suhara, K.I. Nihei, M. Kurihara, A. Kittaka, K. Yamaguchi, T. Fujishima, K. Konno, N. Miyata, and H. Takayama Efficient and versatile synthesis of novel 2alpha-substituted 1alpha,25-dihydroxyvitamin D(3) analogues and their docking to vitamin D receptors J. Org. Chem. 66 26 2001 8760 8771 (Pubitemid 34042239)
29. A. Kittaka, A. Yoshida, K.C. Chiang, M. Takano, D. Sawada, T. Sakaki, and T.C. Chen Potent 19-norvitamin D analogs for prostate and liver cancer therapy Future Med. Chem. 4 16 2012 2049 2065
30. A.J. Annalora, D.B. Goodin, W.X. Hong, Q. Zhang, E.F. Johnson, and C.D. Stout Crystal structure of CYP24A1, a mitochondrial cytochrome P450 involved in vitamin D metabolism J. Mol. Biol. 396 2 2010 441 451
31. J.T. Powers, S. Hong, C.N. Mayhew, P.M. Rogers, E.S. Knudsen, and D.G. Johnson E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis Mol. Cancer. Res. 2 4 2004 203 214 (Pubitemid 39031081)
32. A. Krtolica, N.A. Krucher, and J.W. Ludlow Hypoxia-induced pRB hypophosphorylation results from downregulation of CDK and upregulation of PP1 activities Oncogene 17 18 1998 2295 2304 (Pubitemid 28515382)
33. F.S. Fan, and W.C. Yu 1,25-Dihydroxyvitamin D3 suppresses cell growth, DNA synthesis, and phosphorylation of retinoblastoma protein in a breast cancer cell line Cancer Invest. 13 3 1995 280 286
34. S.S. Jensen, M.W. Madsen, J. Lukas, L. Binderup, and J. Bartek Inhibitory effects of 1alpha,25-dihydroxyvitamin D(3) on the G(1)-S phase-controlling machinery Mol. Endocrinol. 15 8 2001 1370 1380 (Pubitemid 32703484)
35. J. Prudencio, N. Akutsu, N. Benlimame, T. Wang, Y. Bastien, R. Lin, M.J. Black, M.A. Alaoui-Jamali, and J.H. White Action of low calcemic 1alpha,25-dihydroxyvitamin D3 analogue EB1089 in head and neck squamous cell carcinoma J. Natl. Cancer Inst. 93 10 2001 745 753 (Pubitemid 32514797)
36. C.B. Harley, and S.W. Sherwood Telomerase, checkpoints and cancer Cancer Surveys 29 1997 263 284 (Pubitemid 27262249)
37. M. Fossel Cell senescence in human aging and disease Ann. N. Y. Acad. Sci 959 2002 14 23 (Pubitemid 34457547)
38. L. Mao, A.K. El-Naggar, Y.H. Fan, J.S. Lee, S.M. Lippman, S. Kayser, R. Lotan, and W.K. Hong Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues Cancer Res. 56 24 1996 5600 5604 (Pubitemid 26422159)
39. H.Y. Kagata, M. Tsukuda, I. Mochimatsu, A. Kubota, M.K. Furukawa, and S. Yasumoto Telomerase activity of tumors in the head and neck Nihon Jibiinkoka Gakkai Kaiho 101 2 1998 205 211 (Pubitemid 128518314)
40. O. Loughran, L.J. Clark, J. Bond, A. Baker, I.J. Berry, K.G. Edington, I.S. Ly, R. Simmons, R. Haw, D.M. Black, R.F. Newbold, and E.K. Parkinson Evidence for the inactivation of multiple replicative lifespan genes in immortal human squamous cell carcinoma keratinocytes Oncogene 14 16 1997 1955 1964 (Pubitemid 27217808)
41. R. Kasiappan, Z. Shen, A.K. Tse, U. Jinwal, J. Tang, P. Lungchukiet, Y. Sun, P. Kruk, S.V. Nicosia, X. Zhang, and W. Bai 1,25-Dihydroxyvitamin D3 suppresses telomerase expression and human cancer growth through microRNA-498 J. Biol. Chem. 287 49 2012 41297 41309